Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

NPA lawyer: ‘Serious flaws’ justify legal challenge to cuts

“Very serious flaws” in the government's justification for the pharmacy cuts is cause for court action, a lawyer acting on behalf of the National Pharmacy Association (NPA) has said.

Andrea James, a partner at LHS Solicitors, which is acting on behalf of the NPA, is confident that the shortcomings in the Department of Health’s (DH) approach to the proposed £113 million cut to funding in England justifies mounting a legal challenge.

She pointed out that this year the pharmacy organisation has already successfully challenged the government’s claim that expanding hub-and-spoke dispensing will improve patient safety, and help push the intended implementation date of the cuts back from October to December.

The NPA has “explored every possible avenue to help its members”, including negotiations with the government, Ms James told C+D last week (November 4) .

“The NPA has sought, at all times, to behave reasonably and negotiate sensibly with the DH, so legal action was never considered inevitable right up to the publication of the final [funding] package,” she added.

The NPA said last week that it had “no option” but to take its fight against the cuts to court.

The DH has been asked to respond to the legal challenge by 4pm today (November 9). The NPA had not received a response at the time of going to press.

Are you confident a legal challenge will secure concessions for the sector?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel